Skip to main content
BCWORLDPHARM Co., Ltd. logo

BCWORLDPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 200780 ISIN · KR7200780005 KO Manufacturing
Open in API
Filings indexed 192 across all filing types
Latest filing 2024-02-13 AGM Information
Country KR South Korea
Listing KO 200780

About BCWORLDPHARM Co., Ltd.

https://www.bcwp.co.kr

BCWORLDPHARM Co., Ltd. is a technology-driven pharmaceutical company specializing in the research, development, and manufacturing of prescription drugs. The company leverages its core expertise in formulation and process development to produce a diverse portfolio of quality generic medicines. With a significant commitment to research and development, BCWORLDPHARM focuses on creating next-generation pharmaceuticals to address evolving medical needs and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for BC World Pharm. It outlines the date, location, and agenda items (financial statements, election of directors, and remuneration limits). This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and to request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2024-02-13 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from BC World Pharm regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the approval process. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2024-02-13 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from BC World Pharm regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 44th Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal regulatory notice of a corporate action. Given it is a specific regulatory announcement regarding shareholder rights and meeting preparation that does not fit into the other specific categories, it is classified as a Regulatory Filing.
2023-12-14 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from BC World Pharm regarding the setting of a record date for shareholder registry closure to facilitate dividend payments. It specifies the record date (2023-12-31) and the purpose (dividend distribution for the 44th Annual General Meeting). Since this is an announcement of a dividend record date rather than the actual declaration of the dividend amount or payment date, it falls under general regulatory announcements regarding corporate actions.
2023-12-14 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for BC World Pharm, covering the period from 2023-01-01 to 2023-09-30. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-13 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for BC World Pharm, covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial data, business descriptions, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.